Leukocytoclastic vasculitis (cutaneous small-vessel vasculitis) after COVID-19 vaccination

Vaccinations may induce cutaneous adverse events, due to nonspecific inflammation or immuno-mediated reactions. Several types of vasculitis have been observed. We report on a 71-year-old woman who developed cutaneous small-vessel vasculitis after the second dose of Vaxzevria COVID-19 vaccination, sh...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of autoimmunity Vol. 127; p. 102783
Main Authors:	Fiorillo, G., Pancetti, S., Cortese, A., Toso, F., Manara, S., Costanzo, A., Borroni, R.G.
Format:	Journal Article
Language:	English
Published:	England Elsevier Ltd 01-02-2022
Subjects:	Aged COVID-19 vaccine COVID-19 Vaccines - adverse effects Cutaneous small-vessel vasculitis Female Humans Leukocytoclastic vasculitis Neutrophil Infiltration Prednisone - therapeutic use SARS-CoV-2 vaccine Vaccines adverse reactions Vasculitis, Leukocytoclastic, Cutaneous - blood Vasculitis, Leukocytoclastic, Cutaneous - drug therapy Vasculitis, Leukocytoclastic, Cutaneous - etiology Vasculitis, Leukocytoclastic, Cutaneous - pathology Vaxzevria vaccine Leukocytoclastic vasculitis COVID-19 vaccine SARS-CoV-2 vaccine Cutaneous small-vessel vasculitis Vaxzevria vaccine Vaccines adverse reactions
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!